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Stem cells are highly abundant during early develop-
ment but become a rare population in most adult
organs. The molecular mechanisms causing stem
cells to exit proliferation at a specific time are not
well understood. Here, we show that changes in
energy metabolism induced by the steroid hor-
mone ecdysone and the Mediator initiate an irrevers-
ible cascade of events leading to cell-cycle exit in
Drosophila neural stem cells.We show that the timely
induction of oxidative phosphorylation and the mito-
chondrial respiratory chain are required in neuro-
blasts to uncouple the cell cycle from cell growth.
This results in a progressive reduction in neuroblast
cell size and ultimately in terminal differentiation.
Brain tumor mutant neuroblasts fail to undergo this
shrinkage process and continue to proliferate until
adulthood. Our findings show that cell size control
can be modified by systemic hormonal signaling
and reveal a unique connection between metabolism
and proliferation in stem cells.
INTRODUCTION
Stem cells exit proliferation at defined times during develop-
ment. When organogenesis is completed, they enter senes-
cence, differentiate, or die (Iglesias-Bartolome and Gutkind,
2011) so postnatal animals or adults contain much lower
numbers of stem cells (Kalyani and Rao, 1998; Cai et al.,
2002). Persistence of embryonic stem cell populations into adult-
hood results in tumorigenesis (Blum and Benvenisty, 2008) and
stem cells in tumors often regain embryonic properties (Janic
et al., 2010). Understanding how the timely disappearance of
stem cell populations is coordinated with developmental timing
is therefore important for both stem cell and tumor biology.
Drosophila neural stem cells are called neuroblasts (NBs) and
provide a tractable system to study stem cell proliferation and
terminal differentiation (Kohlmaier and Edgar, 2008; Sousa-
Nunes et al., 2010; Chang et al., 2012; Homem and Knoblich,874 Cell 158, 874–888, August 14, 2014 ª2014 Elsevier Inc.2012). NBs divide asymmetrically into a larger cell that maintains
stem cell identity and a smaller cell committed to differentiation.
This is achieved through the differential segregation of the kinase
aPKC into the larger daughter cell and the cell fate determinants
Numb, Prospero, and Brat into the smaller daughter cell (Hirata
et al., 1995; Knoblich et al., 1995; Rolls et al., 2003; Betschinger
et al., 2006). When the machinery for asymmetric cell division is
perturbed, NBs accumulate leading to the formation of massive
brain tumors that can be transplanted and become metastatic
over time (Gateff, 1978; Gateff et al., 1993; Caussinus and Gon-
zalez, 2005; Betschinger et al., 2006; Lee et al., 2006; Wang
et al., 2006).
During larval stages, NBs divide hundreds of times to self-
renew and generate differentiated neurons or glia. After every
division, eachNB re-grows to its original size and thereforemain-
tains a constant volume throughout larval development (Ito and
Hotta, 1992; Homem et al., 2013). During the pupal stages,
NBs continue dividing for a limited time but disappear before
adult stages (White and Kankel, 1978; Truman and Bate, 1988)
leading tominimal or no proliferation in the adultDrosophila brain
(von Trotha et al., 2009; Ferna´ndez-Herna´ndez et al., 2013). As
distinct NB subpopulations disappear at different times (Truman
and Bate, 1988), cell-cycle exit is not simply a response to a sys-
temic program. Distinct mechanisms have been postulated for
the timely disappearance of various subgroups of NBs. In the
abdominal ventral nerve cord (VNC), NBs die by apoptosis (Bello
et al., 2003) whereas a combination of apoptosis and autophagy
eliminates the mushroom body NBs, a particularly long-lived
subpopulation of NBs in the central brain (CB) (Siegrist et al.,
2010). In the majority of CB NBs, however, a terminal symmetric
division preceded by a reduction in cell size terminates the pro-
liferative state at a specific time during pupal development
(Maurange et al., 2008).
The mechanisms that trigger terminal symmetric division or
apoptosis at a specific time are currently not understood. Like
Drosophila embryonic NBs, larval NBs in the thoracic region of
the VNC progress through distinct temporal stages expressing
specific transcription factors in a temporally defined manner
(Maurange et al., 2008; Chai et al., 2013). How these temporal
factors ultimately lead to stem cell exit is unclear.
Here, we show that a change in NB metabolism induced by
the steroid hormone ecdysone and the Mediator complex at
the larval to pupal transition leads to a reduction in cell growth
and to uncoupling between cell size and cell-cycle progression
that is responsible for terminal differentiation. Our study shows
that the connection between cellular growth and cell-cycle
progression can be under developmental control and reveals
a connection between transcription regulation of metabolism
and stem cell terminal differentiation. It further suggests a mech-
anism by which metabolism regulates cancer cell proliferation.
RESULTS
Cell-Autonomous Growth Reduction Precedes
Proliferation Exit in NBs
CBNBs constitute the larger population of NBs in theDrosophila
brain and are classified into 86 type I, four mushroom body
(MB), and eight type II NBs. Type I and MB NBs divide to
generate one NB and one ganglion mother cell (GMC) that di-
vides once more to produce two neurons or glia cells. Type II
NBs give rise to one NB and one intermediate neural progenitor
(INP) that can self-renew a limited number of times generating
one INP and one GMC. Both type I and type II NBs express
the cortical marker Miranda (Mira) while only type I NBs also ex-
press the nuclear transcription factor Asense (Ase) (Bello et al.,
2008; Bowman et al., 2008).
Stem cell proliferation in the CB is ended by a symmetric ter-
minal division of a smaller sized NB (Maurange et al., 2008). To
identify the events leading to this terminal division, we quanti-
fied cell size and growth rates at various times. Both type I
and type II pupal NBs became smaller during pupal develop-
ment (Figures 1A–1C and Figure S1F available online). Plotting
cell diameter versus the time after pupa formation (APF) re-
vealed that the different types of NBs reduced their size at
different rates. Type II NBs and posterior type I NBs started
larger, but lost volume more rapidly, reaching the size of their
daughter INPs or GMCs, respectively, at 16 hr APF (Figures
1C and S1F), at which point NBs disappeared (Figures S1C–
S1E). Anterior type I NBs, in contrast, started off smaller but
shrank more slowly. They divided for a longer period and disap-
peared around 24 hr APF when they were as small as their
daughter GMCs (Figures 1C, S1A, S1B, S1E, and S1F). Volu-
metric calculations revealed that the rate of cell size reduction
for each NB type corresponds to the volume lost to generate
differentiated daughter cells (Figures S1G–S1I), indicating that
a reduction in cell growth could lead to proliferation exit of CB
Drosophila NBs.
The larva to pupa transition is accompanied by dramatic
changes in tissue and organism growth (Cheng et al., 2011;
Sousa-Nunes et al., 2011), and altered nutrient supply could
explain cell size reduction. To test the cell autonomy of NB
shrinking and to quantify growth and cell-cycle length, we
used a long-term culture system (Homem et al., 2013). Like
in vivo, both type I and type II larval and pupal NBs could divide
multiple times in culture (Figures 1D and 1E; Movies S1 and S2;
data not shown).While larval NBs re-grew to their original size af-
ter each division (Figures 1D and 1H), pupal NBs cultured under
the same conditions did not re-grow and therefore became pro-
gressively smaller (Figures 1E and 1H) until they underwent an
equal size symmetric cell division (Figure 1E, arrow heads in22:24). Quantification of cell cycle and growth indicates that
pupal NB size reduction is not due to an accelerated cell cycle;
in fact during this stage NB cell cycle was slower (Figure 1G).
Thus, a cell-autonomousmodification of cell growth characteris-
tics precedes proliferation exit in Drosophila NBs.
Defects in asymmetric cell division trigger brain tumor forma-
tion in flies. Tumorous NBs no longer exit the cell cycle and can
persist into adulthood (Loop et al., 2004). To test whether this is
accompanied by a loss of cell size control, we cultured pupal
NBs from flies expressing a transgenic brat RNAi construct
(bratIR). bratIR pupal NBs were still able to divide multiple times,
but unlike wild-type (WT) pupal NBs, remained big and were
indistinguishable from larval NBs (Figures 1F and 1H; Movie
S3). As the cell cycle duration of bratIR pupal NBs was not signif-
icantly different from pupal NBs (Figure 1G), we concluded that
tumor NBs lose the ability to reduce growth in response to a
developmental program. Taken together, these results suggest
that a specific cellular program triggered during pupal stages
causes Drosophila NBs to exit proliferation by inhibiting cellular
growth in a cell-autonomous fashion.
NB Shrinkage Is Not Regulated by Common Cell Death
or Growth Control Pathways
As the insulin/target of rapamycin (TOR) pathway (Greer and
Brunet, 2005) has been shown to regulate lifespan in MB NBs
(Siegrist et al., 2010), we activated or inhibited insulin signaling
and analyzed pupal brains at 24 hr APF when the majority of
type I and all type II NBs have disappeared (Figure S1E). Activa-
tion of insulin signaling by overexpressing the insulin-like pep-
tides (ILPs) ILP2 and ILP5 or a constitutively active insulin
receptor InR (InRCA), or by RNAi of its effector FOXO did not pre-
vent NB cell-cycle exit (Figures 2A–2E and S2A). Conversely, in-
hibition of insulin signaling using dominant negative InR (InRDN),
or FOXO overexpression also did not influence NB disappear-
ance (Figures 2F, 2G, and S2A).
PI3K is a convergence point of multiple growth signaling path-
ways (Cheng et al., 2011). We therefore overexpressed PI3K
(Figure 2H), its downstream effector AKT (Figures 2I and S2A)
as well as the PI3K downstream effectors and TOR activators
Ras homolog enriched in brain (Rheb) and S6K in pupal
NBs (Figures 2J, 2K, and S2A). Although activation of PI3K or
AKT/TOR did not cause any observable phenotypes in larval
stages, neither was sufficient to prevent pupal NB shrinkage
and disappearance (Figures 2O, 2P, and S2A). Together, these
data show that the insulin/TOR and PI3K pathways are not suffi-
cient to promote NB growth or prevent NB cell-cycle exit and
disappearance.
Under starvation conditions, autophagy can be activated
(Chang et al., 2009). Inhibition of this pathway with a dominant
negative form of autophagy-specific gene 1 (UAS-ATG1K38Q)
(Siegrist et al., 2010) caused no effect in CB NB size or number
in late pupal stages (Figures 2L, 2O, 2P, and S2A). Similarly, in-
hibition of apoptosis by overexpressing antiapoptotic p35 (Hay
et al., 1994) was not capable of preventing pupal NB disappear-
ance (Figures 2M, 2O, 2P, and S2A).
Finally, decreasing reactive oxygen species by overexpress-
ing superoxide dismutase 1 (SOD1) did not change pupal NB
number or size (Figures 2N–2P and S2A). These results indicateCell 158, 874–888, August 14, 2014 ª2014 Elsevier Inc. 875
Figure 1. Pupal NBs Reduce Their Size In Vivo and In Vitro in a Cell-Autonomous Manner
(A and B) In vivo staining of WT third instar larval (3IL) and pupal brains. Mira (red), Ase (blue), CD8::GFP (green). (A) Type I (anterior), (B) type II NBs.
(C) NB size variation over time of anterior type I and type II NBs in vivo.
(D–F) Single frames from time-lapse movies of cultured type II NBs expressing UAS-Stinger::RFP under the control of wor-Gal4,ase-Gal80. (D) Third instar larval
NBs (LNB). (E) White pupal NBs (PNB). (F) bratIR PNB. Asterisk labels NB. White arrowheads label the two equal sized daughter cells. Times in hr:min.
(G) Quantification of cell-cycle time of cultured larval, pupal, and pupal bratIR type II NBs.
(H) Automated quantification of volume variation with each cell division of culturedWT larval, pupal, and bratIRpupal type II NBs. Scale bars represent 10 mm. Error
bars represent ±SEM. *p < 0.05.
See also Figure S1 and Movies S1, S2, and S3.
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Figure 2. PI3K/Insulin, TOR, Autophagy, or Apoptosis Are Not Involved in NB Terminal Disappearance
(A–N) Fixed brains 24 hr APF. Type II driver Gal4 line driving expression of indicated transgene. Mira, red; Ase, blue; CD8::GFP, green.
(O and P) Quantification of type II NB diameter (O) and type II NB number (P) in the posterior side of larva and 24 hr APF brains of the indicated genotype. Out of the
eight type II NBs per brain lobe, six are located in the posterior side and two are more anterior. Scale bars represent 10 mm. Error bars represent ±SEM.
See also Figure S2.that there must be yet unknown mechanisms that regulate pupal
NB growth and are responsible for their disappearance.
A Genome-wide RNAi Screen for NB Life Span
and Growth
As none of the known regulatory pathways explain NB shrinkage,
we carried out a genome-wide in vivo RNAi screen for extended
or reduced NB life span (Figure 3A). To streamline the protocol,
we expressed a transgene encoding firefly luciferase together
with RNAi lines from the Vienna Drosophila Research Center
KK collection in CB type II NBs and their progeny. Although
these transgenes are no longer expressed in adults, pilot exper-
iments revealed considerable perdurance of luciferase activity
into adulthood (data not shown). We used CB type II NBs
because they are not essential for fly viability, allowing us to
also probe the effect of genes essential for cell survival on lucif-
erase expression. For each RNAi line, six heads from 1-day-old
adults were homogenized in 96-well plates. Luciferase activity
wasmeasured in triplicates (Figure 3B) and signals were normal-
ized to the average of theWT control. In total, we screened 9,700
RNAi lines each corresponding to a different gene (70% of the
Drosophila protein coding genome). The vast majority of thesecaused either no change or a reduction in luciferase activity
(Figure 3C). This is expected as NB cell death or mitotic arrest
caused by RNAi of cell essential genes should decrease lucif-
erase activity.
To identify genes inducing timely disappearance of NBs, we
focused on a subset of 388 genes where at least one of the lucif-
erase reads wasmore than 4-fold higher than the control and the
variation coefficient for the three samples was below 0.4 (Table
S1). Gene Ontology (GO) term analysis of these 388 genes
revealed that the category of stem cell differentiation was over-
represented (Figure 3D, nodes with blue border, p = 0.002). This
includes known tumor suppressor genes and NB temporal tran-
scription factors. Their knock down results in adult NB prolifera-
tion (Bello et al., 2006; Maurange et al., 2008) nicely confirming
our screening strategy. Analysis of protein-protein and genetic
interactions between the identified genes revealed three distinct
interaction clusters (Figure 3D). One cluster contained genes
with no GO term enriched and was not pursued further (Fig-
ure 3D, gray outline, s = 2.5). A second cluster included five
members of the Mediator complex (Figure 3D, red outline, s =
1.8), while the third cluster contained three genes involved in
oxidative phosphorylation (OxPhos) (Figure 3D, green outline,Cell 158, 874–888, August 14, 2014 ª2014 Elsevier Inc. 877
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Figure 3. In Vivo Whole-Genome Screen to Identify Regulators of NB Shrinking and Cell-Cycle Exit
(A) Screen principle and expected outcomes.
(B) Screen procedure.
(C) Histogram with screen distribution of Luciferase values. x axis = log2 of average Luciferase fold change versus internal background.
(D) Gene network analysis of RNAi lines above cutoff. Nodes with blue edge, GO term:stem cell differentiation; red outline, cluster of Mediator complex members;
green outline, OxPhos genes; gray outline, cluster containing genes of broad biological function.
See also Table S1.s = 1). We focused on these genes for further analysis as
they had not previously been connected to proliferation control
in NBs.
The Mediator Complex Is Necessary to Induce Pupal
NB Shrinkage
Mediator is a highly conserved protein complex of 26–30 sub-
units that connects transcription factors to RNA Polymerase II
(Malik and Roeder, 2010; Conaway and Conaway, 2013; Napoli
et al., 2012). Mediator maintains the pluripotent state of embry-
onic stem cells by binding so-called super enhancers and acti-
vating the transcriptional network for maintaining the ES cell
state (Kagey et al., 2010; Whyte et al., 2013).
As we identified multiple Mediator subunits in our screen (Fig-
ure 3D), we analyzed the RNAi phenotype of the complex sub-
units in pupal NBs. To test if these genes are involved in NB
disappearance, we performed this phenotypic analysis of NBs878 Cell 158, 874–888, August 14, 2014 ª2014 Elsevier Inc.at 24 hr APF, a time point when most type I and all type II NBs
have already disappeared in the WT. Transgenic RNAi con-
structs targeting eight Mediator subunits (Med4, Med6, Med9,
Med10, Med11, Med22, Med27, Med31) prolonged lifetime
and prevented shrinkage of both type I (Figures S3E–S3I and
data not shown) and type II NBs (representative examples in Fig-
ures 4A–4D, quantified in Figures 4E and 4F). RNAi of all these
Mediator subunits did not have any obvious effect on larval
NBs (Figures S3A–S3D, S3L, and S3M). These RNAi phenotypes
are specific as they could be confirmed by a secondary RNAi line
(Figure S3I). In addition, NB lifespan could also be prolonged by
expressing Med12 (Kohtalo, Kto), an inhibitory subunit that has
been shown to repress Mediator function (Malik and Roeder,
2010) (Figures 4E, 4F, and 4K). To determine if these longer lived
NBs continue proliferating we stained them for phosphohistone
H3 (PH3), a marker of mitotic cells. In WT 24 hr pupal brains,
we never detect PH3-positive NBs (0 of 15 brains scored). In
pupal brains expressing med27IR, however, several PH3-posi-
tive NBs could be found, showing that NBs divide for a longer
time (Figures S4A and S4F). To test whether prolongation of
NB life-span produces excess neuronal progeny in vivo, we
generated permanently labeled clones ofmed27IR. We analyzed
clones originating from posterior type I NBs, which normally
disappear at 16 hr APF. Clones were generated during larval
stages and analyzed 5 days later, at 24 hr APF or 28 hr APF.
Indeed, NBs depleted of med27 generated significantly more
neuronal progeny than WT (Figures 4L–4P). Thus, the Mediator
complex is required for timely reduction of cell size and for
limiting proliferation in Drosophila NBs. However, Mediator is
not a general inhibitor of cell growth. Expression of two indepen-
dent med27IR in wing imaginal discs led to small and abnormal
wings (Figures S3J and S3K).
To test whether Mediator acts in a cell-autonomous manner,
we cultured pupal type II NBs expressing med27IR. med27IR
pupal NBs did not reduce their net size, behaving like larval
NBs (Figures 4G–4I; compare Movies S2 and S4) in spite of
dividing with similar cell-cycle timings as WT pupal NBs (Fig-
ure 4J). Taken together, our results indicate that Mediator acts
in a cell-autonomous fashion to promote a switch in NB growth
that initiates exit from mitotic proliferation.
Mediator Regulates Ecdysone Targets and Metabolic
Enzymes in Pupal NBs
To identify the mechanism by which Mediator regulates NB pro-
liferation, we determined its transcriptional targets. We isolated
WT larval NBs, WT pupal NBs, and mediator RNAi pupal NBs
by fluorescence-activated cell sorting (FACS) and determined
transcript levels by RNA-sequencing (Figure S4M). Mediator
function was inhibited by an RNAi line that reduces med27
mRNA levels by 90% (VDRC TID 106703) in NBs. To avoid indi-
rect effects from cell size differences, we analyzed mRNA levels
0–2 hr APF when NBs are still present and are not yet strongly
reduced in size (Figure S4M). This identified a set of 1,355
genes that were differentially regulated between WT larval and
pupal NBs (fragments per kilobase of transcript per million frag-
ments mapped [FPKM] >10, p < 0.01, log2-fold change >0.5;
accession number GSE53265). Interestingly the majority of
these (879 of 1,355 genes) were upregulated in pupal NBs, sug-
gesting that pupal NBs might be transcriptionally more active
(Figure S4N).
In insects, the transition from larval to pupal stages is called
metamorphosis and is triggered by a pulse of the steroid hor-
mone ecdysone. Upon ligand binding, the ecdysone receptor
(EcR) translocates into the nucleus where it first induces expres-
sion of a small group of early response genes, which mostly
encode transcription factors. These early regulatory proteins
then coordinate the expression of late response genes that ulti-
mately induce morphological changes (Ou and King-Jones,
2013). As expected, the genes differentially expressed between
larval and pupal NBs were enriched for the GO categories meta-
morphosis/ecdysone signaling, neuronal differentiation and
response to stimuli (Table S2).
Interestingly, genes downregulated in pupal NBs were en-
riched for metabolism and energy production (Table S2). To
test if this difference in expression from larva to pupa is Medi-ator-dependent we next compared WT and med27IR pupal
NBs. We identified 732 genes that were significantly differentially
expressed. GO term analysis of this set of genes revealed enrich-
ment for both metamorphosis and metabolism.
Hierarchical clustering of our transcript data with a very strin-
gent cutoff (FPKM >10 and fold change >2) revealed a group of
genes that were highly upregulated in WT but not inmed27IR pu-
pal NBs (Figure 5A). Among these are several ecdysone early
induced genes (Eig) that are expressed at much lower levels in
med27IR pupal NBs (Figure 5A, black line). These data were
confirmed by qPCR: Eig were not expressed in larval NBs but
were highly expressed in pupal NBs. Upon Mediator depletion
withmed27RNAi or inhibition of ecdysone signaling with a domi-
nant negative form of the EcR (EcRDN), Eig expression was
severely reduced (Figure 5B). Thus, Med27 is required for EcR
activity in NBs.
To test a more general requirement of Mediator for ecdysone
signaling, we analyzed mushroom bodies, where ecdysone is
known to specify the cell fate of late born a/b neurons (Kucher-
enko et al., 2012). As expected, EcR RNAi prevented proper dif-
ferentiation of a/b neurons resulting in a smaller volume (Figures
5C, 5D, and 5G) (Kucherenko et al., 2012). Formation of the late
born a/b neurons was completely prevented by EcRDN (Fig-
ure 5E) indicating that the dominant negative receptor has a
stronger effect than RNAi. As expression ofmed27 RNAi closely
mimicked the phenotype of EcRRNAi and also prevented proper
formation of a/b neurons (Figures 5D and 5F), we conclude that
Mediator is required for EcR-induced morphological changes in
mushroom bodies as well.
What could be the relationship between Mediator and ecdy-
sone signaling? Mediator RNAi did not affect EcR transcription
levels (accession number GSE53265) nor did it disrupt EcR
subcellular localization in larval or pupal NBs (Figures S4O and
S4P). Co-immunoprecipitation (coIP) experiments revealed that
Mediator binds to the EcR (Figure 5H), indicating that Mediator
does not affect EcR directly but is required for ecdysone-
induced transcription instead, possibly forming a complex with
the active receptor on chromatin.
We therefore tested whether ecdysone signaling might be the
temporal trigger that changes cell growth in NBs. As the VDRC
KK collection does not contain an RNAi line targeting EcR and
it was therefore not included in our screen, we used an indepen-
dent EcR RNAi line and also EcRDN. When expressed in NBs,
both EcRDN and EcR RNAi prevented pupal NB shrinkage in
type I NBs (average diameter at 24 hr APF: WT = 5.2 mm,
EcRDN = 10.4 mm) and type II NBs (Figures 5I–5K). Pupal NB
shrinkage is also prevented when ecdysone signaling is inhibited
by expressing the EcR ligand binding domain (Kozlova and
Thummel, 2002), thereby sequestering ecdysone hormone (Fig-
ures S4Q and S4R). Similar results were observed upon expres-
sion of a dominant negative version of Taiman (Tai-nls-LXXLL)
(Jang et al., 2009), a histone-modifying enzyme required for
EcR to regulate transcription (Bai et al., 2000) (Figure 5L). Despite
the defects, cultured pupal NBs expressing EcRDN were mitot-
ically active and divided asymmetrically (Figures 5M and 5N). In-
hibition of EcR in vivo effectively led to mitotically active (Figures
S4B and S4F) and longer-lived NBs, resulting in increased num-
ber of the neuronal progeny generated (Figures S4G, S4H, andCell 158, 874–888, August 14, 2014 ª2014 Elsevier Inc. 879
(legend on next page)
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S4L). Thus, ecdysone signaling is essential for NBs to transit
from the proliferating to the shrinking stage and timely cell-cycle
exit.
Mediator-Induced Metabolic Changes Are Required for
NB Shrinkage
Besides ecdysone signaling, our transcriptome analysis re-
vealed a number of key metabolic enzymes downregulated in
med27IR pupal NBs. These include enzymes in major metabolic
pathways, such as glycolysis, Krebs cycle, fatty acid meta-
bolism, purine metabolism, pentose phosphate pathway, as
well as alanine, aspartate, glutamate, glutathione, galactose,
glycerolipid, and nitrogen metabolism (accession number
GSE53265). Most of the enzymes that were deregulated in
med27IR NBs catalyze reversible reactions, which complicate
their analysis. However, we also found several enzymes control-
ling the irreversible, rate-limiting steps of metabolic pathways.
This set includes phosphofructokinase (Pfk) catalyst of a rate-
limiting step of glycolysis; adenosine 3 (ade3), a predicted phos-
phoribosylglycinamide synthetase catalyzing an irreversible step
in purine biosynthesis; CG5214, a predicted E2 member of the
a-ketoglutarate dehydrogenase complex (a-KGDHC) that cata-
lyzes a rate-limiting step in the Krebs cycle; and pyruvate
carboxylase (PC, CG1516), a mitochondrial enzyme catalyzing
the conversion of pyruvate to oxaloacetate formultiplemetabolic
pathways (Figure 6A).
The levels of a-KGDHC, PC, and ade3 increased from larva to
pupa and as expected this increase was abrogated in both
med27IR and EcRDN backgrounds (Figure 6A). Pfk was not
found to be differentially expressed between larval and pupal
NBs and thus was not pursued further (Figure 6A). To test if the
differentially expressed enzymes are required for NB shrinkage
we individually knocked down a-KGDHC, PC, and ade3. RNAi
of PC and ade3 had no effect on pupal NBs (Figure 6B).
a-KGDHCRNAi, in contrast, prevented NB shrinkage (Figure 6B)
and prolonged NB life span in pupae (Figures 6B–6E, S4D, S4F,
S4J, and S4L) while it had no effect in larval NBs (Figure S5B).
Thus, a-KGDHC seems to play a particularly important role in
inducing NB shrinkage.
a-KGDHC is a key regulatory enzyme complex in the Krebs cy-
cle (Figure 6F) (Cooney et al., 1981) that generates NADH, the
key substrate for the respiratory chain. Inhibition of a-KGDHC
leads to a reduction in NADH levels (Tretter and Adam-Vizi,
2000; see also Figure 7C below) and, as a consequence, oxida-
tive phosphorylation (OxPhos) (Tretter and Adam-Vizi, 2000;
McLain et al., 2011). It was therefore interesting that one of theFigure 4. The Mediator Complex Is Necessary to Induce Pupal NB Shr
(A–D) Fixed brains 24 hr APF. Mira, white. WT, med10IR, med27IR, med31IR. Sca
(E and F) Number of type II NBs (E) and type II NB diameter (F) in the posterior s
(G and H) Single frames from time-lapse movies of cultured type II NBs expressin
Asterisk labels NB; arrowheads point progeny of final symmetric division. Scale
(I) Quantification of cell size variation with each division of WT and med27IR pup
(J) Cell cycle duration of WT larval NBs (LNB), WT pupal NBs (PNB), and pupal m
(K) Cartoon of the Mediator complex based on Malik and Roeder (2010). Mediat
(L–O) Fixed 24 hr APF or 28 hr APF brains with 120-hr- or 124-hr-old permanently
(L and N) WT. (M and O) med27IR. (L0–O0 ) Deeper z stack slice. Scale bar repres
(P) Quantification of progeny number in FlipOut clones of indicated genotypes. Er
See also Figures S3 and S4 and Movie S4.clusters identified in our screen contained multiple components
of OxPhos (Figure 3D). We thus tested the effect of reducing Ox-
Phos on NB shrinkage. Complete or near-complete inhibition of
OxPhos by rotenone caused a cell-cycle block in NBs and could
therefore not be used. We therefore used RNAi lines targeting
various components in the mitochondrial electron transport
chain reasoning that RNAi would only partially inhibit OxPhos
because these components are among the most highly ex-
pressed genes in NBs (Berger et al., 2012) (described below).
Transgenic RNAi lines targeting ubiquinol-cytochrome c oxido-
reductase 14 kDa (Ucrh, CG3560, KK line, and independent sec-
ondary short hairpin RNAi line), cytochrome c oxidase subunit Va
(CoVa, CG14724), cytochrome c oxidase polypeptide VIIc (CoA-
VIIc, CG2249), and cytochrome c oxidase IV (CoxIV, CG10664)
did not prevent proliferation when expressed in type II larval
NBs (Figures S5A–S5F). In pupal NBs, however, RNAi of any of
these OxPhos components increased cell size and extended
life span (Figures 6G–6K, S4C, S4F, S4I, S4L, and S5I). When
kept in culture, pupal NBs with reduced expression of the Ox-
Phos regulator Ucrh divided normally and generated the correct
neuronal lineage but the shrinkage observed in WT pupal NBs
was completely prevented (Figure S5H). Taken together, these
results suggest that regulation of OxPhos is at the heart of the
metabolic changes induced by Mediator that lead to cell-cycle
exit in pupal NBs.
We also observed that RNAi of CG7834, an electron transfer
flavoprotein beta subunit (ETF) prevented pupal NB shrinkage
and increased pupal NB life-span (Figures 6L, S4E, S4F, S4K,
and S4L), while having no effect in larval stages (Figure S5G).
ETFs link oxidation of fatty acids and amino acids to oxidative
phosphorylation, and disruption of ETFs results in fat and pro-
tein accumulation (Frerman and Goodman, 1985). The fact that
both depletion of ETFs and OxPhos components prevent NB
shrinkage and timely differentiation, suggests that OxPhos de-
pletes metabolites for biosynthesis and thereby reduces growth
and induces NB shrinkage in pupae.
Differences in Energy Metabolism between Larval and
Pupal NBs
To measure Mediator- and ecdysone-dependent metabolic
changes, we first quantified oxygen consumption rates (OCR)
in larval and pupal Drosophila brains. To avoid indirect effects
from cell size differences, we analyzed metabolite levels 0–2 hr
APF when NBs are not yet strongly reduced in size. Our experi-
ments revealed a highly significant increase in OCR from larval to
pupal stages (Figure 7A). This increase became statisticallyinkage in a Cell-Autonomous Manner
le bars represent 20 mm.
ide of brains 24 hr APF of indicated genotypes.
g Stinger::RFP under the control of wor-Gal4, ase-Gal80. (G) WT. (H)med27IR.
bars represent 10 mm.
al NBs in culture.
ed27IR NBs. Times in hr:min. Error bars represent ±SEM.
or components required for NB shrinkage in red.
labeled FlipOut posterior type I NB clones. Pros, blue; GFP, green; Mira, red.
ents 10 mm.
ror bars represent ±SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant.
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Figure 5. Ecdysone and Mediator Act Together to Induce NB Shrinkage and Disappearance
(A) Hierarchical heat map of genes differentially expressed in both WT and med27IR NBs with FPKM >10 and fold change >2. Black line outlines ecdysone
signaling cluster.
(B) qPCR analysis of Eig expression in FACS-sorted NBs of the indicated stages and genotypes versus WT PNB.
(C–F) Fixed adult brainmushroombody neuronal projections. Single frames from stacks, red line outlines a-b projection. (C)WT. (D) EcRIR. (E) EcRDN. (F)med27IR.
Scale bars represent 20 mm.
(G) Cartoon of MB neuronal projections.
(H) Co-IP of EcR with GFP-Med27.
(I–L) Fixed brains 24 hr APF expressing indicated transgene in type II NBs. (I) WT. (J) EcRDN. (K) EcRIR. (L) TaimanLXXLGFP (DN). Scale bars represent 20 mm.
(M and N) Single frames of time lapse movies of type II cultured pupal WT NBs (M) and pupal NBs expressing EcRDN (N). Asterisk labels NB. Scale bars represent
10 mm; time in hr:min.
See also Table S2 and Figure S4.
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Figure 6. Mediator Transcriptionally Regulates the Metabolic Switch Necessary to Induce Pupal NB Shrinkage
(A) Fold change expression levels of a-KGDHC (CG5214), PC (CG1516), Pfk (CG4001), and ade3 (CG31628) in indicated genotypes and stages measured by
qPCR. Values normalized versus WT larval NBs.
(B) Type II NB number in posterior side of brains 24 hr APF of indicated genotypes.
(C and D) Type II NBs in fixed 24 hr APF brains. Mira, red; Ase, blue; GFP, green; asterisk labels NB. (C) WT. (D) a-KGDHCIR.
(E) Quantification of diameter of type II NBs in 24 hr APF brains.
(F) Cartoon depicting glycolysis, Krebs cycle a-KGDHC, and the respiratory chain.
(G, H, and I–L) Fixed 24 hr APF. Mira, red; GFP, green; Ase, blue; asterisk labels NB. (G) WT type II lineage lacking a NB. (H) UcrhIR. (I) CoAVIIcIR. (J) CoxIVIR. (K)
CoVaIR. (L) CG7834IR (ETF). Scale bars represent 10 mm. Error bars represent ±SEM. ***p < 0.001; ****p < 0.0001; ns, not significant.
See also Figure S5.nonsignificant when we depleted med27 by RNAi or ecdysone
signaling with EcRDN in NBs (Figure 7A). Thus, Mediator and
ecdysone induce a change in metabolic flux that contributes to
the increase in OxPhos. As med27IR or EcRDN were only ex-
pressed in NBs, we conclude that upregulation of OxPhos in
NBs is largely responsible for the increase in OCR within the
Drosophila brain.
As reducing OxPhos prevented shrinkage of pupal NBs, we
next tested the metabolic consequences of directly inhibiting
the respiratory chain by RNAi of the complex III componentUcrh. RNAi of Ucrh in NBs reduced OCR rates as expected (Fig-
ure 7B). At the same time, NADH levels were significantly
increased (Figure 7B). Importantly, however, overall energy/
ATP levels were unchanged in UcrhIR brains (Figure 7B). We
conclude from the decrease in OCR and increase in NADH levels
that themitochondrial electron chain is partially blocked and that
there is less aerobic respiration with a consequent accumulation
of NADH.
To test if these metabolic changes are an indirect conse-
quence of changes in mitochondrial morphology, we stainedCell 158, 874–888, August 14, 2014 ª2014 Elsevier Inc. 883
Figure 7. OxPhos Is Required for NB Shrinkage and Timely Disappearance
(A–C) Quantification of whole-brain oxygen consumption rates (OCR), NADH, lactate, and ATP. Brains expressing indicated dsRNA under the control of NB-
specific insc-Gal4. LB, third instar larval brains; PB, 0–2 hr pupal brains. Data are presented as ratios to WT LB. Note that controls are identical in these panels.
Error bars represent ±SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, ns, not significant. Brain number analyzed per genotype/stage: OCR > 30; NADH,
lactate, ATP > 45.
(D) Model.
See also Figures S6 and S7.mitochondria. Mitochondria showed a punctate pattern in larval
and early pupal brains, including the stages when NB shrinkage
occurs. After 8–10 hr APF, however, mitochondria became fused
and displayed significant morphological alterations. As those
changes occur both in NBs and the surrounding tissues, are
unaffected by RNAi of Mediator, ecdysone, Uchr, or a-KGDHC,
and occur long after the start of NB shrinkage (Figure S6), we
conclude that they are not responsible for the size reduction
in NBs.
To get an estimate of the amount of anaerobic glycolysis
occurring when OxPhos is inhibited, we measured lactate
levels. In WT brains, lactate levels strongly decreased from
larval to pupal stages. In UcrhIR animals, however, lactate
levels were reduced and unchanged between larval and pupal
stages (Figure 7B). It is interesting to note that a reduction in
OxPhos levels did not cause an increase in lactate as one
would predict if glycolysis and OxPhos were in an isolated
equilibrium. In reality, however, multiple biosynthetic and en-
ergy storage pathways feed from glycolytic intermediate me-
tabolites, and accumulating metabolites will be redistributed
in the metabolic network depending on the context of the cell
(McKnight, 2010).
We next tested whether the metabolic profile of NBs depleted
of Mediator or EcR is similar to the one resulting from OxPhos884 Cell 158, 874–888, August 14, 2014 ª2014 Elsevier Inc.inhibition. Upon reducing Mediator or ecdysone activity, lactate
levels were significantly lower in larvae and slightly higher in pu-
pae, effectively reducing the difference between the two stages
(Figure 7C). Consistent with the observed reduction in OCR in
brains expressing EcRDN, we also observed a decrease in
NADH levels. Overall, the effect of EcRDN was stronger than
the one caused by med27 RNAi. We assume this is due to a
stronger effect of EcRDN on the pathway, consistent with the
stronger phenotypes observed in mushroom bodies (Figures
5C–5E). Direct reduction of NADH levels and consequently Ox-
Phos by depleting NBs of a-KGDHC also attenuated the differ-
ence in lactate levels between larva and pupa (Figure 7C). In
spite of the observedmetabolic changes for all these genotypes,
the overall energy/ATP level did not change (Figure 7C). Thus,
although we have found a-KGDHC as a major target of Mediator
and ecdysone, changes of this enzyme alone cannot explain the
metabolic changes that we observe in pupal stages. The striking
cellular phenotypes of a-KGDHC, med27, or EcR RNAi, how-
ever, suggest that those other metabolic changes are not suffi-
cient for NB shrinkage.
Taken together, our data indicate that ecdysone- and Medi-
ator-induced alterations of glucose and energy metabolism
initiate a cascade of events that ultimately ends the proliferative
phase in Drosophila neural stem cells (Figure 7D).
DISCUSSION
Mediator- and Steroid Hormone-Induced Growth
Reduction Precedes Terminal Differentiation
The mechanisms that couple cell-cycle progression to cell
growth are still controversial (Lloyd, 2013). It is thought that
cellular growth rates are influenced by nutrient availability (La-
porte et al., 2011) and extracellular growth factors. Our data indi-
cate, however, that the major reduction of Drosophila NB growth
at the larva to pupa transition is independent of the insulin
pathway, the major sensor for extracellular nutrient supply. We
show that ecdysone signaling is required for this change, sug-
gesting that it is initiated by the larva-pupa pulse of ecdysone
(Ou and King-Jones, 2013). Once the switch has occurred, how-
ever, it is stably maintained as the differences in growth behavior
are maintained in co-cultures of larval and pupal NBs even under
identical ecdysone levels (Figures 1D and 1E).
Our results are consistent with previous observations showing
that a series of transcriptional regulators confers temporal iden-
tity to NBs (Grosskortenhaus et al., 2005; Maurange et al., 2008).
Seven-up (Svp) is the last transcription factor in this series. It is
expressed until early pupal stages and required for timely NB dif-
ferentiation (Chai et al., 2013; Ou and King-Jones, 2013). It is un-
likely that ecdysone simply triggers the transition to another, not
yet identified transcription factor in this series. First, our analysis
did not identify a transcriptional regulator that is upregulated in
pupal NBs and required for shrinkage (data not shown). Second,
Svp expression is not lower in pupal compared to larval NBs
(aAccession number GSE53265). More likely, therefore, ecdy-
sone acts by modifying the Svp temporal state. Interestingly,
Svp can compete for EcR bindingwith the EcR dimerization part-
ner Ultraspiracles (Usp) and inhibit ecdysone-induced meta-
morphosis (Zelhof et al., 1995), suggesting that the connection
between steroid hormone signaling and the temporal cascade
may in fact be very direct.
EcR has been shown to cooperate withmultiple chromatin and
transcriptional regulators (Badenhorst et al., 2005; Kirilly et al.,
2011; Kugler et al., 2011). Our data add the Mediator complex
to this list. As mammalian Mediator interacts with estrogen
receptor and is necessary for estrogen receptor-mediated
transcription (Zhang et al., 2005), it may play a general role in
transmitting steroid hormone signals. Because only a subset of
Mediator subunits are required for pupal NB regulation while
RNAi of other subunits causes cell lethality (data not shown),
it could be a specific subcomplex that performs the function
in NBs. In vertebrates, specific Mediator subunits interact with
individual transcription factors and affect gene expression
controlled by these coregulators. Like its mammalian counter-
part, Drosophila Mediator could have cell type/developmental
stage-specific functions (Figure S3) (Zhang et al., 2005; Jiang
et al., 2010) that depend on its subunit composition.
In mammals, steroid hormone signaling is also involved in pro-
liferation control. Prolonged presence of androgens and estro-
gens is implicated in the development of prostate and breast
cancer, respectively (Pike et al., 1993; Culig and Santer, 2014).
In fact most of the established prostate and breast cancer treat-
ments are designed to modulate steroid hormone production or
response. The present study provides mechanistic connectionsbetween steroid hormone signaling, energymetabolism, and cell
proliferation regulation that could impact on those treatments.
Upregulation of OxPhos Is Required for Stem Cell
Terminal Differentiation
Our results show that Mediator induces changes in a large num-
ber of metabolic enzymes. It is therefore surprising that inhibition
the E2 member of a-KGDHC alone can mimic the Mediator
phenotype. a-KGDHC is a major redox sensor (McLain et al.,
2011) and responsible for generating NADH, thus its inhibition
is capable of preventing oxidative glucose metabolism. We pro-
pose that this results in the accumulation of metabolites, which
can feed into biosynthetic pathways promoting NB growth and
proliferation (Figure S7). Consistent with this, OxPhos levels
are increased in pupal brains and NB shrinkage is prevented
by a reduction in OxPhos. In addition, we have found that deple-
tion of ETF also prevents NB shrinkage and prolongs NB life-
span. ETF deficiency is the primary cause of Glutaric acidemia
type II, a human metabolic disorder where reduced oxidation
of lipids and amino acids leads to excess accumulation of fat
and protein (Frerman and Goodman, 1985). Prevention of catab-
olism with consequent accumulation of biomolecules could
therefore also explain the reduced shrinkage we observe upon
ETF RNAi in NBs.
Stem Cells and Metabolism
Unlike their differentiated counterparts, stem cells and induced
pluripotent stem cells (iPS) (Simsek et al., 2010) rely heavily on
anaerobic glycolysis instead of aerobic respiration. The switch
from mitochondrial oxidative metabolism to glycolysis is also
observed in most proliferative cells and our data indicate that
this may be the cause and not just a consequence of differenti-
ation. Interestingly, cancer cells primarily depend on glycolysis
(Warburg, 1956) metabolizing glucose to lactic acid even in the
presence of oxygen, a phenomenon commonly known as the
Warburg effect. It is believed that reduced OxPhos promotes
metabolic flux from intermediates of glycolysis into biosynthetic
branches, allowing cell proliferation. Again, our data could indi-
cate that this is causative for neoplastic development rather
than a result of malignant transformation.
Because mammalian Mediator has been implicated as a regu-
lator of both steroid hormone signaling (Jiang et al., 2010) and
stem cell fate (Kagey et al., 2010; Whyte et al., 2013) we propose
that the role of Mediator as a metabolic regulator in stem cells is
conserved in mammalian systems. It will be interesting to test if
defects in uncoupling stem cell cycle from growth contribute to
neoplastic transformation of these cells.
EXPERIMENTAL PROCEDURES
Fly Strains and Immunohistochemistry
w1118 was used as WT for all immunofluorescence experiments. RNAi lines
were obtained from the ViennaDrosophilaRNAi center, and TriP lines were ob-
tained from the Bloomington Stock Center. UAS-GFP-Med27 and the short
hairpin RNA line for CG3560 were generated in this study. Fly crosses were
set up and grown at 29C to increase UAS/Gal4 expression and fluorescence
intensity. Fixation and staining of larval brains were performed as previously
described (Betschinger et al., 2006). Pupae were collected as white pupae
and aged for the desired number of hours at 29C. Adobe Photoshop 7.0Cell 158, 874–888, August 14, 2014 ª2014 Elsevier Inc. 885
was used to adjust input levels to span entire output grayscale and to adjust
brightness and contrast. See also Extended Experimental Procedures.
Cell Dissociation, Primary Cell Cultures, and Live Imaging
Third instar larvae or white pupae were dissected, enzymatically and mechan-
ically dissociated and immediately plated in 0.01% poly-L-lysin-hydrobro-
mide-coated glass bottom cell culture dishes and allowed to settle for 1 hr
at room temperature. Before imaging, 1 ml of primary cell-culture Schneider’s
medium (Homem et al., 2013) was added to each chamber and imaging was
performed immediately. See also Extended Experimental Procedures.
RNA Sequencing
RNAi line for med27 (TID106703) or the WT control TID60100 (empty Landing
site VIE-260B) were crossed to UAS-dicer2;insc-Gal4 UAS-CD8::GFP (type I
and type II NB driver). Brains from third instar larvae or white pupa were
dissected and dissociated as for live imaging. Dissociated brains were sorted
by FACS (FACS Aria III, BD) (Berger et al., 2012), and NBs were directly
collected into TRIzol (Invitrogen). mRNA and cDNA were prepared as
described in Harzer et al. (2013). Sample sequencing was performed on Hi-
seq2000. See also Extended Experimental Procedures.
Metabolic Assays
UAS-RNAi lines, UAS-EcRDN or w1118 were crossed to UAS-dicer2;insc-
Gal4 UAS-CD8::GFP. The same number of adult flies was used to ensure equal
diet. Because isolation of enough number of living NBs by FACS sorting was
technically not possible, we performed these metabolic analyses with entire
brains. Green third instar larvae or pupae 0–2 hr APF were selected and
their brains dissected, collected in the appropriate lysis buffer in dry ice,
and prepared according to kit instructions. Respiration rates were measured
in real-time using a Seahorse XF-24 analyzer (Seahorse Bioscience). Each
experiment was done with three to five technical replicas and performed
independently at least three times. For inter-experiment comparison, all mea-
surements were internally normalized versus internal WT larva. Statistical
significance was evaluated by t test. See also Extended Experimental
Procedures.
Co-IP and Western Blots
For coIP, larval brains expressing UAS-GFP-Med27 under the control of insc-
Gal4 were used. tub-GFPwas used as control. Thirty third instar larval brains of
each genotype were dissected and collected in ice cold Rinaldini solution. Pro-
tein samples were prepared by grinding brains in low salt buffer (Tris-HCl
50 mM, NaCl 100 mM, MgCl2 10 mM, EDTA 1 mM, 10% glycerol, 0.5% NP-
40, protease inhibitors) with a plastic pestle. Immunoprecipitate was done
with GFP-Trap beads (Chromotek). Immunoblots were blocked with dry milk
and primary antibodies anti-EcR (DDA2.7, DSHB) and anti-GFP (Jl8-Clontech)
were used at a dilution of 1:500 and 1:1,000, respectively. Signal was detected
by ECL (Amersham).
ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the data reported
in this paper is GSE53265.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, four movies, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2014.06.024.
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